Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The compound was never approved as a pharmaceutical treatment for obesity because the Phase 2 clinical trial results, while showing safety and modest efficacy, did not meet the threshold for drug registration
AOD 9604 is mostly backed by animal study data, with limited human clinical evidence available in peer-reviewed literature
Ideal for those seeking better recovery, sharper thinking, and improved metabolic function
Under Dr
US$ 22.90
US$ 20.22
US$ 28.72
US$ 27.32
US$ 25.84
US$ 28.75
US$ 25.64
US$ 24.42
US$ 27.27
US$ 22.85
